Status:
RECRUITING
Prevention of Emergence Agitation in Rhinoplasty With Subanesthetic Propofol and Single-Dose Dexmedetomidine: A Prospective Double-Blind Clinical Study
Lead Sponsor:
Yuzuncu Yil University
Conditions:
Emergence Agitation
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
To compare of prevention of emergence agitation in rhinoplasty with subanesthetic propofol and single dose dexmedetomidine
Detailed Description
The study will have a double-blind design and will be conducted after obtaining an approval from the local ethics committee. The study will include 80 patients planned for elective rhinoplasty, aged 1...
Eligibility Criteria
Inclusion
- Patients scheduled for rhinoplasty
- Between 18-65 years
- ASA I-II group
Exclusion
- Those who are outside the age range of 18-65
- Those who are ASA III and above
- Those with renal,hepatic, cardiac and respiratory diseases
- Those with a known allergy to the medication to be used
- Those who underwent urinary catheterization
Key Trial Info
Start Date :
April 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT07144007
Start Date
April 15 2025
End Date
February 1 2026
Last Update
August 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Van Yüzüncü Yıl University
Van, Tuşba, Turkey (Türkiye), 65100